FDA issues EUA for Boehringer Ingelheim's IVOMEC (ivermectin) 1% Injection

Cumberland Pharmaceuticals secures FDA Fast Track status for DMD heart‑disease therapy ifetroban

Hologic receives FDA approval for Aptima HPV assay as primary screening option

AbbVie submits FDA and EMA applications for new upadacitinib indication in NSV

Relay Therapeutics wins FDA breakthrough status for zovegalisib in breast cancer treatment

DATROWAY receives US priority review for first-line metastatic triple negative breast cancer

Lupin launches Dasatinib tablets in US market

Natera submits Signatera CDx PMA to FDA for bladder cancer use

Pharming receives FDA complete response letter for paediatric Joenja application

Trace Biosciences' IND application for nerve-specific imaging agent approved by FDA

Frontage expands early phase clinical research capabilities across US and China

MicuRx Pharmaceuticals' IND application for MRX-5 cleared by FDA

FDA approves Tenpoint Therapeutics' YUVEZZI as first dual-agent eye drop for presbyopia

Summit Therapeutics' BLA for ivonescimab in EGFR-mutated NSCLC accepted by FDA

WuXi Biologics collaborates with Sinorda Biomedicine for antibody development